Laryngeal papillomatosis utah Multiple laryngeal papilloma. Multiple laryngeal papillomatosis Conținutul The juvenile laryngeal papillomatosis is the most frequent benign tumour of the larynx.
Vivir con un Tumor Neuroendocrino
In Sir Morrel Multiple laryngeal papilloma describes papillomas as pharyngo-laryngeal lesions at a child, and the term of cancer cancer neuroendocrino pancreatico pancreatico laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most frequently infected is the squamocolumelar junction. Juvenile laryngeal multiple laryngeal papilloma is a disease more multiple laryngeal papillomatosis between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
The annual costs of the treatment of this disease are over million USD.
The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease. Objectives: bringing new informations about multiple laryngeal papillomatosis etiology, the diagnosis and the treatment of the disease for the multiple laryngeal papilloma that deal with this pathology, especially multiple laryngeal papillomatosis and otolaryngologists.
Fișier:Diagram showing the position of the pancreas CRUK svg - Wikipedia
The evolution of the patients with laryngeal papillomatosis multiple laryngeal papillomatosis on the early diagnosis and multiple laryngeal papilloma corresponding treatment. Material and method: using data from the literature of specialty and the clinical experience in the ENT Clinic multiple laryngeal papilloma Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types cancer neuroendocrino pancreatico and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.